MSI2 and B-cell chronic lymphocytic leukemia: Since downregulation of MSI2 led to reduced CLL-cell survival, we determined the basis for this using a human apoptosis array and protein extracts from MEC1 cells treated with siMSI2 and siCTR (Fig. S9A).